Genomics Lab Director for Hematologic Malignancies

Automatic Data Processing, Inc.; San Diego (CA); On-site; USD 280,000 - 380,000; Full time

Job summary

Bionano Laboratories, the RUO and CLIA/CAP services business unit of Bionano Genomics, seeks a board-certified pathologist and/or laboratory geneticist with extensive experience in hematologic malignancies and genomic interpretation. The role includes oversight of cytogenetic/molecular testing and proficiency testing, with emphasis on integrating multiple genomic modalities for clinical utility.

The candidate will work with management to evaluate new technologies and support publications and

Qualifications

• Requires MD/PhD or equivalent in pathology or molecular genetics.
• Board certification or eligibility in LGG or Clinical Cytogenetics/genomics.
• Clinical Laboratory Director licensure for high-complexity testing.

Responsibilities

• Oversee proficiency testing and quality reports.
• Design/approve validation plans and reports.
• Sign-out of clinical diagnostic OGM data with clinical context.
• Update clinical tools and reference files for interpretation.
• Contribute to publications and conferences.
• Interpret complex genomic findings in hematologic malignancies.

Skills

Hematologic malignancies knowledge

Genomics interpretation

Communication skills

Leadership management

Regulatory knowledge (CLIA/CAP)

Proficiency testing & QA

Education

MD or PhD in pathology/genetics

Board certification in LGG or clinical cytogenetics

Tools

CMA/CMA CMA analysis tools

FISH, cytogenetics platforms

NGS workflows

Job description

Bionano Laboratories, the RUO and CLIA/CAP services business unit of Bionano Genomics, seeks a board-certified pathologist and/or laboratory geneticist with extensive experience in hematologic malignancies and genomic interpretation. The role includes oversight of cytogenetic/molecular testing and proficiency testing, with emphasis on integrating multiple genomic modalities for clinical utility.

The candidate will work with management to evaluate new technologies and support publications and